Research and Development

Showing 15 posts of 9596 posts found.

Manchester research hub appoints industry liaison

August 19, 2009 Research and Development Academic, NHS

The Manchester Biomedical Research Centre (BRC) has appointed a new industry-facing executive to forge new research links with the industry.Dr …

Novartis’ Extavia approved in US

August 19, 2009 Research and Development, Sales and Marketing Extavia, MS, Novartis

 Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …

US pharma accused of selling out to Obama

August 19, 2009 Research and Development, Sales and Marketing US, US healthcare, healthcare, industry

The US industry is accused of selling out to President Obama’s healthcare take-over, with its leaders seeking favourable treatment from …

Off-label rules for cancer need to be clarified

August 18, 2009 Research and Development, Sales and Marketing Cancer, NHS, off label

A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …

ClinPhone accounts give Parexel a hangover

August 18, 2009 Research and Development Clinphone

Accounting errors at recently-acquired ClinPhone pegged back Parexel's operating profits in its latest quarterly reports, and it will be some …

GSK starts first trials for H1N1 vaccine in Germany

August 17, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GSK is to embark on the clinical development for its pandemic swine flu vaccine, completing enrolment into its first study …

Genzyme says Cerezyme shortages could last longer than expected

August 17, 2009 Research and Development, Sales and Marketing Gaucher, Genzyme

The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …

Vulnerable groups first in line for UK swine flu jabs

August 14, 2009 Research and Development, Sales and Marketing NHS, h1n1

The first 11 million people to receive jabs against the H1N1 virus have been announced by the government, ready for …

Animal rights attacks were terrorism not activism, says Vasella

August 13, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …

AZ signs antibiotic deal with Forest Laboratories

August 13, 2009 Research and Development, Sales and Marketing Antibiotics, Forest

AstraZeneca has struck a deal with Forest Laboratories to co-develop and commercialise ceftaroline, an anti-infective drug in phase III. The …

Authorised generics deals likely here to stay, says analyst

August 12, 2009 Research and Development, Sales and Marketing generics

The practice of branded drugmakers paying rivals to keep generics off the market after product patent expiry – known as …

EMEA makes adverse drug reaction research a priority

August 12, 2009 Research and Development, Sales and Marketing Europe, drug safety

Adverse drug reaction in hyperactive children has been made a key research priority for next year by the European Medicines …

New FDA head aims for aggressive enforcement

August 11, 2009 Research and Development, Sales and Marketing FDA, US, drug safety

The new head of US regulator the FDA has set out a vision to support public health, through tighter laws …

Skills council for pharma

August 11, 2009 Research and Development, Sales and Marketing Jobs, training

The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …

Contract research news in brief

August 11, 2009 Research and Development CRO, Omnicom

Pharmafocus presents its periodic round-up of developments in the contract research sector, including updates from Pharm-Olam, OmniComm, SIRO, Ecron Acunova …
The Gateway to Local Adoption Series

Latest content